TITLE

LETTERS

AUTHOR(S)
Marras, T.K.; Chan, C.K.; Loeb, Mark; McGeer, Allison; Simor, Andrew
PUB. DATE
June 2002
SOURCE
Clinical & Investigative Medicine;Jun2002, Vol. 25 Issue 3, p63
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a discussion on an observational study on the use of antibiotic guidelines for pneumonia in chronic-care facilities. Details of the study; Recommendations issued by the commentators; Reaction of the authors to the commentary.
ACCESSION #
6979674

 

Related Articles

  • Antibiotic Prescribing. Flanders, Scott; Gonzales, Ralph // JGIM: Journal of General Internal Medicine;Feb2002, Vol. 17 Issue 2, p160 

    Editorial. Assesses the issues on antibiotic prescribing for the treatment of community-acquired pneumonia in the U.S. Aspects of antibiotic treatment; Examination of antibiotic resistance; Factors influencing the choice of antibiotic treatment.

  • Evolution of Antibiotic Use and Cost in Patients with Community-Acquired Pneumonia. Sabbatani, S.; Cesari, R.; Pipitone, E. // Clinical Drug Investigation;2002, Vol. 22 Issue 9, p601 

    Objective: To investigate the evolution and efficiency of the clinical management (particularly shift therapy) of patients with community-acquired pneumonia (CAP) in a hospital setting. Study design and methods: This was a retrospective analysis of 120 hospitalised patients who were treated with...

  • High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradigm. Dunbar, Lala M.; Wunderink, Richard G.; Habib, Michael P.; Smith, Leon G.; Tennenberg, Alan M.; Khashab, Mohammed M.; Wiesinger, Barbara A.; Xiang, Jim X.; Zadeikis, Neringa; Kahn, James B. // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p752 

    Examines the use of high-dose, short-course levofloxacin as a treatment paradigm for community-acquired pneumonia. Demonstration of concentration-dependent bactericidal activity related to the pharmacodynamic parameters of the ratio of area under the concentration-time curve to minimum...

  • Antibiotics for pneumonia: few comparative data.  // New Zealand Doctor;5/7/2014, p38 

    The article discusses the usage of antibiotics for the treatment of pneumonia and mentions the release of the "Antibiotics: choices for common infections" guidelines released in New Zealand in 2013.

  • Vibativ Approved for Serious Pneumonia.  // Monthly Prescribing Reference;Aug2013, Vol. 29 Issue 8, pA18 

    The article informs that the U.S. Food and Drug Administration (FDA) has approved the Vibativ, a lipoglycopeptide antibiotic, for the treatment of patients with hospital acquired and ventilator-associated bacterial pneumonia caused by the bacteria, Staphylococcus aureus, as of August 2013.

  • PCP PREVENTION ALERT. Delaney, Martin // Advocate;11/19/91, Issue 590, p37 

    Reports on the medical alert received by physicians from the U.S. National Institutes of Health concerning the prevention of second bouts of Pneumocystis carinii pneumonia. Call for monthly treatments with aerosol pentamidine; Superiority of the oral use of two common antibiotics.

  • Grepafloxacin Activity Against 3000 Canadian Respiratory Tract Pathogens. Hoban, D.J.; Zhanel, G.G.; Palatnick, L.; Weshnoweski, B.; Vercaigne, L.; Karlowsky, J.A. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p358 

    Attempts to determine the in vitro activities of antibiotics prescribed to treat community-acquired pneumonia against respiratory tract pathogens collected in Canada in 1997-1998. Materials and methods; Results; Discussion.

  • Grepafloxacin Activity Against 3000 Canadian Respiratory Tract Pathogens. Hoban, D.J.; Zhanel, G.G.; Palatnick, L.; Weshnoweski, B.; Vercaigne, L.; Karlowsky, J.A. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p358 

    Attempts to determine the in vitro activities of antibiotics commonly prescribed to treat community-acquired pneumonia against respiratory pathogens collected in Canada. Materials and methods; Results; Discussion.

  • Optimal Use of Modern Antibiotics; Emerging Trends. Polk, Ron // Clinical Infectious Diseases;8/1/1999, Vol. 29 Issue 2, p264 

    Examines the trends in the components of optimal use of antibiotics. Definition of optimal use of antibiotics; Costs of specific antibiotics for treatment of community-acquired pneumonia in patients not requiring hospitalization; Pharmacodynamic relationships that quantify the exposure of a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics